Latest Hypertension News
The researchers found that scores on the cognitive tests were linked with the patient's systolic blood pressure.
In mild AF-related acute ischemic stroke, rivaroxaban and warfarin had comparable safety and efficacy.
Targeting and treating systolic blood pressure to a lower range was associated with a 14% decreased risk of death, meta-analysis shows.
Targeting a systolic blood pressure below 120 mm Hg versus 135 to 139 mm Hg increased the absolute risk of incident CKD by 2.6% over 3 years, but decreased the risk of cardiovascular events or death.
People who increased their weight by as little as 5% were more likely to have thickening and enlargement of the left ventricle.
The researchers found that there was an increase in NOAC use over time, warfarin use did not change, and overall anticoagulant use increased.
After 11 pounds gained, the risk of diabetes went up 31%, hypertension 14%, and cardiovascular disease 8%.
There was no significant difference between the groups in secondary end points or the decreases in NT-proBNP levels achieved.
The researchers found patients on intensive blood pressure treatment fared as well as those on standard care.
In a study of African Americans with hypertension-related CKD, metoprolol, but neither ramipril nor amlodipine, increased serum uric acid levels.
The AAP published updated clinical practice guidelines for the diagnosis and treatment of children with hypertension.
The researchers found that the readmission rate was 18.19% among 5552 patients.
Women at high risk for preeclampsia who took 150 mg of aspirin daily during pregnancy had 62% lower odds of developing the condition.
The researchers found higher estimated cardiovascular risks associated with marijuana use than cigarette smoking.
Fewer VTE events were observed in the betrixaban than enoxaparin arm.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)